Počet záznamov: 1
baziliximab
SYS d000077552 LBL 00000nx^^^2200181-^^45^^ 005 20240119195330.3 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a baziliximab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2019 (1998) $8 eng 330 1-
$a A chimeric murine-human monoclonal antibody that functions as an INTERLEUKIN 2 RECEPTOR antagonist by binding to the alpha chain (CD25 ANTIGEN) of the interleukin-2 receptor on the surface of activated T-LYMPHOCYTES. It is used in the prevention of acute graft rejection episodes in patients undergoing renal transplantation. $8 eng 450 $a CHI 621 $5 e $8 slo 450 $a SDZ CHI 621 $5 e $8 slo 450 $a Simulect $5 e $8 slo 450 $a basiliximab $5 e $8 slo 686 $a D12.776.124.486.485.114.224.060.344 686 $a D12.776.124.790.651.114.224.060.407 686 $a D12.776.377.715.548.114.224.200.407 750 $a Basiliximab $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190322 980 $x M
Počet záznamov: 1